Aspira Pathlab & Diagnostics Board of Directors

Get the latest insights into the leadership at Aspira Pathlab & Diagnostics. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Haseeb Drabu Chairman & Ind.Director
Dr. Pankaj J Shah Managing Director & CEO
Mr. Nikunj Mange Executive Director
Mr. Manas Mengar Independent Director
Mr. Avinash C Mahajan Independent Director
Mrs. Mangala K Prabhu Independent Director

Aspira Pathlab & Diagnostics Share price

ASPIRA

64

0.13 (0.20%)
Last updated on 4 Sep, 2025 | 14:21 IST
BUYSELL
Today's High

64.00

Today's Low

61.00

52 Week Low

30.00

52 Week High

106.78

The current prices are delayed, login to your account for live prices

Aspira Pathlab & Diagnostics FAQs

The board at Aspira Pathlab & Diagnostics consists of experienced professionals, including Dr. Haseeb Drabu , Dr. Pankaj J Shah , and others, overseeing the company’s strategic and corporate governance.

Directors at Aspira Pathlab & Diagnostics are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Haseeb Drabu is the current chairman at Aspira Pathlab & Diagnostics.

Executive directors at Aspira Pathlab & Diagnostics are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Aspira Pathlab & Diagnostics adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Aspira Pathlab & Diagnostics, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.